Aescin

Clinical trial

Mechanism of Action

Inhibits elastase and hyaluronidase, reducing capillary permeability and vascular fragility

Research Notes

Aescin demonstrates significant reduction in capillary filtration rate and edema in clinical trials for venous insufficiency. Stabilizes vascular endothelium through protease inhibition. Widely used in European phlebology for chronic venous disease.

Found In 1 Herb

Horse Chestnut

Western

3D Molecular Structure

Triterpene saponin

Drag to rotate · Click atoms to explore

Aescin

Triterpene saponinAromatic plant metabolites with anti-inflammatory properties

Representative pattern: C₁₁H₁₄O₆

Atoms

Carbon

Oxygen

Related Compounds (Triterpene saponin)

Asiaticoside(1)Eclalbatin(1)Larreagenin A(1)Madecassoside(1)Phytolaccagenin(1)

Live Research

Open on PubMed

This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare practitioner before using any herbal product.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This content is for educational purposes only and is not a substitute for professional medical advice.